ArticleFrontiers in neurology2023

Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS study.

Raed Al-Roughani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.